Risk and Benefit of Oral Anticoagulants in Atrial Fibrillation

被引：0
|
作者：
Zotova, I. V. [1 ]
Zateyshchikov, D. A. [1 ]
机构：
[1] President RF, FSI Educ Sci Med Ctr, Gen Management Dept, Moscow 121356, Russia
来源：
KARDIOLOGIYA | 2011年 / 51卷 / 10期
关键词：
atrial fibrillation; indirect anticoagulants; thromboembolism; bleeding; risk stratification; CLINICAL CLASSIFICATION SCHEMES; MAJOR BLEEDING COMPLICATIONS; SOLUBLE CD40 LIGAND; WARFARIN THERAPY; STROKE RISK; VENOUS THROMBOEMBOLISM; ARTERIAL EMBOLISM; NATIONAL REGISTRY; PREDICTING STROKE; ISCHEMIC-STROKE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Thromboembolism is the main cause of death and disability of patients with atrial fibrillation. Indirect anticoagulants are effective means of primary and secondary prevention of thromboembolic complications. However in a number of patients risk associated with therapy with indirect anticoagulants might exceed potential benefit. The principle problem requiring solution in a patient with atrial fibrillation is individual comparative assessment of risk of development of thromboembolic and hemorrhagic complications. Modern stratification scales which allow solving this problem are considered in this review.
引用
收藏
页码：81 / 91
页数：11
相关论文
共 50 条
  • [1] Quantitative Risk-Benefit Analysis of Oral Anticoagulants in Patients with Atrial Fibrillation
    Hsu, Jason C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 387 - 387
  • [2] Novel Oral Anticoagulants in Atrial Fibrillation: Will the Benefit Outweigh the Cost?
    Goudevenos, John
    Pipilis, Athanasios
    Vardas, Panos
    [J]. HELLENIC JOURNAL OF CARDIOLOGY, 2012, 53 (02) : 137 - 141
  • [3] Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis
    Mendoza-Sanchez, Jose
    Silva, Federico
    Rangel, Lady
    Jaramillo, Linda
    Mendoza, Leidy
    Garzon, Jenny
    Quiroga, Andrea
    [J]. PLOS ONE, 2018, 13 (05):
  • [4] Oral anticoagulants in patients with atrial fibrillation: fracture risk
    [J]. Reactions Weekly, 2020, 1791 (1) : 10 - 10
  • [5] Novel Oral Anticoagulants for Atrial Fibrillation
    Hankey, Graeme J.
    Eikelboom, John W.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2013, 15 (08)
  • [6] New Oral Anticoagulants for Atrial Fibrillation
    Spinler, Sarah A.
    Shafir, Valerie
    [J]. CIRCULATION, 2012, 126 (01) : 133 - 137
  • [7] Novel oral anticoagulants for atrial fibrillation
    Mahtani, Kamal R.
    Heneghan, Carl
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [8] Oral anticoagulants in diabetes and atrial fibrillation
    Vieweg, A.
    Standl, E.
    Schnell, O.
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2007, 16 (03): : 179 - 182
  • [9] New oral anticoagulants in atrial fibrillation
    Veltkamp, R.
    Hacke, W.
    [J]. NERVENARZT, 2011, 82 (02): : 180 - +
  • [10] Novel oral anticoagulants for atrial fibrillation
    How, Choon How
    [J]. SINGAPORE MEDICAL JOURNAL, 2015, 56 (12) : 657 - 659
12345